Y-Intercept (HK)’s GSK GSK Stock Holding History

Y-Intercept (HK)’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-24,289	Closed	-$1.27M	–	1772
2026 Q2	$1.27M	Sell	24,289 -24,875	-51%	-$1.32M	0.03%	937
2026 Q1	$2.71M	Buy	+49,164	New	+$2.66M	0.05%	576
2025 Q4	–	Sell	-5,589	Closed	-$241K	–	1716
2025 Q3	$241K	Sell	5,589 -17,250	-76%	-$674K	0.01%	1437
2025 Q2	$877K	Buy	+22,839	New	+$873K	0.02%	997
2024 Q4	–	Sell	-53,078	Closed	-$2.17M	–	1373
2024 Q3	$2.17M	Sell	53,078 -15,977	-23%	-$654K	0.13%	188
2024 Q2	$2.66M	Buy	+69,055	New	+$2.9M	0.15%	175
2024 Q1	–	Sell	-43,888	Closed	-$1.63M	–	1520
2023 Q4	$1.63M	Sell	43,888 -31,038	-41%	-$1.11M	0.15%	182
2023 Q3	$2.72M	Buy	74,926 +45,943	+159%	+$1.63M	0.27%	84
2023 Q2	$1.03M	Sell	28,983 -60,007	-67%	-$2.15M	0.11%	282
2023 Q1	$3.17M	Buy	88,990 +52,456	+144%	+$1.84M	0.37%	33
2022 Q4	$1.28M	Sell	36,534 -48,071	-57%	-$1.6M	0.19%	137
2022 Q3	$2.49M	Buy	+84,605	New	+$3.21M	0.25%	104
2022 Q1	–	Sell	-22,110	Closed	-$1.22M	–	809
2021 Q4	$1.22M	Buy	+22,110	New	+$1.15M	0.29%	85
2021 Q3	–	Sell	-17,006	Closed	-$846K	–	751
2021 Q2	$846K	Buy	+17,006	New	+$817K	0.22%	130

Other funds holding GSK

Mondrian Investment Partners London, United Kingdom $5.39B AUM 14.53% 1-Year Est. Return

BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return

Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

ABC Arbitrage Paris, France $1.02B AUM 30.46% 1-Year Est. Return

Foster Victor Wealth Advisors Greenville, South Carolina $2.02B AUM 20.94% 1-Year Est. Return

Sound Income Strategies Ft Lauderdale, Florida $2.24B AUM 8.38% 1-Year Est. Return

Euro Pacific Asset Management Dorado, Puerto Rico $1.22B AUM 22.48% 1-Year Est. Return

Keystone Financial Planning Cleveland, Ohio $404M AUM 16.77% 1-Year Est. Return

Bell Bank Fargo, North Dakota $2.66B AUM 18.07% 1-Year Est. Return

Y-Intercept (HK)'s GSK Position: Q3 2026 in Review

Y-Intercept (HK) sold out of GSK (GSK) in Q3 2026, closing a stake of 24,289 shares — an estimated $1.27M sold.

Y-Intercept (HK) first reported a position in GSK in Q2 2021 and held it in 14 quarters. The position peaked at $3.17M in Q1 2023. 266 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

Y-Intercept (HK) reported no remaining GSK position as of Q3 2026 after selling out during the quarter.
Y-Intercept (HK) sold 24,289 GSK shares in Q3 2026, an estimated $1.27M.
Y-Intercept (HK) first reported a position in GSK in Q2 2021 and held it in 14 quarters.
Y-Intercept (HK)'s GSK position peaked at $3.17M in Q1 2023.
266 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.